Quantitative evaluation of HIV prevention programs
By: edited by Edward H. Kaplan and Ron Brookmeyer.
Contributors: Brookmeyer, Ron.
Series: The Institution for Social and Policy Studies at Yale University. Yale ISPS series; Yale ISPS series
Publisher: Yale University Press
Published: 2002
Place of publication: New Haven [Conn.]
Language: eng
Number of pages: 335
Subjects: AIDS (Disease) -- Prevention -- Congresses.; AIDS (Disease) -- Prevention -- Government policy -- Evaluation -- Congresses.
Genres: Congresses.
Notes: Includes bibliographical references and index.
Table of contents: value: Overview of HIV prevention programs in developing countries / Michael H. Merson and Julia M. Dayton; value: Implications of economic evaluations for national HIV prevention policy makers / David R. Holtgrave and Steven D. Pinkerton; value: Statistical issues in HIV prevention / Ron Brookmeyer; value: Epidemiological issues in the evaluation of HIV prevention programs / Nancy S. Padian and Stephen C. Shiboski; value: Difficult choices, urgent needs: optimal investment in HIV prevention programs / Margaret L. Brandeau; value: Methadone treatment as HIV prevention: cost-effectiveness analysis / Harold Pollack; value: Costs and benefits of imperfect HIV vaccines: implications for vaccine development and use / Douglas K. Owens, Donna M. Edwards, and Ross D. Shachter; value: Harm-reduction in Rome: a model-based evaluation of its impact on the HIV-1 epidemic / Massimo Arcà, Teresa Spadea, Giulia Cesaroni, Marina Davoli, Annette D. Verster, and Carlo A. Perucci; value: Evaluating Israel's Ethiopian blood ban / Edward H. Kaplan; value: Feedubg strategies for children of HIV-infected mothers: modeling the trade-off between HIV infection and non-HIV mortality / James G. Kahn, Elliot Marseille, and Joseph Saba; value: Design of HIV trials for estimating external effects / Thomas Philipson; value: Estimation of vaccine efficacy for prophylactic HIV vaccines / Ira M. Longini, Jr., Michael G. Hudgens, and M. Elizabeth Halloran; value: Health policy modeling: epidemic control, HIV vaccines, and risky behavior / Sally Blower,m Katia Koelle, and John Mills; value: Development and validation of a serologic testing algorithm for recent HIV seroconversion / Glen A. Satten, Robert S. Janssen, Susan Stramer, and Michael P. Busch; value: Issues in quantitative evaluation of epidemiologic evidence for temporal variability of HIV infectivity / Stephen C. Shiboski and Nancy S. Padian.